Home >
Products in Development
Text Size make text size smaller make text size largerPrint print this page
Click on compounds in pipeline
for more information

Products in Development

COMPOUND DISCOVERY PRECLINICAL PHASE 1 PHASE 2 PHASE 3
Voreloxin          
Acute Myeloid Leukemia bar graph chart element bar graph chart element bar graph chart element bar graph chart element  
Platinum-Resistant Ovarian Cancer bar graph chart element bar graph chart element bar graph chart element bar graph chart element  
SNS-314          
Advanced Solid Tumors bar graph chart element bar graph chart element bar graph chart element    
Voreloxin

Advanced Hematologic and Solid Tumor Malignancies

SNS-314

Potent and Selective Inhibitor of Aurora Kinases A, B, and C for Advanced Solid Tumors

Ongoing Partnered Programs

Products in development by other pharmaceutical companies

Voreloxin:ONCOLOGY

Phase 2 study of Voreloxin as a treatment for patients with acute myeloid leukemia

Clinical Trial Info MOA Voreloxin
Voreloxin:ONCOLOGY

Phase 2 study of Voreloxin as a treatment for women with platinum-resistant ovarian cancer

Clinical Trial Info MOA Voreloxin
SNS-314:ONCOLOGY

Phase 1 study of SNS-314 for patients with a cancer of solid organ tissue

Clinical Trial Info MOA SNS-314
Clinical Trial Information
Get general information about clinical studies, and learn about Sunesis investigational drugs currently in clinical trial.
click here to learn more
Partnering
Strategic alliances allow us to expand our development and marketing efforts.
click here to learn more